Результаты комплексного и комбинированного лечения инвазивного рака мочевого пузыря
Каприн Андрей Дмитриевич, Добровольская Наталья Юрьевна, Шестаков Алексей Владимирович et al. · Вестник Российского научного центра рентгенорадиологии Минздрава России · 2011
Objective: Evaluation of results of integrated and combined treatment of invasive bladder cancer is given. Materials and Methods: 90 patients with bladder cancer at the stage T2-Т3аN0M0 were included in the investigation. They got treatment in FSI Russian Scientific Rentgenradiology Centre (for the period 2003 2008). The first group consisted of 43 patients after combined treatment (chemoradiotherapy, SOD 6668 Gy). The second group of 47 patients got integrated treatment (transurethral resection of bladder cancer with chemoradiotherapy, SOD 48-50 Gy). Results: 5-year recurrence-free survival rate in the 2-d group of patients is significantly higher than in the 1-st group (48.9% and 16.3%, respectively, p0.05). In the 1-st group the survival rate of patients at T2-stage is significantly lower than in the 2-d group (19.2% and 53.3%, respectively, p>0.05). But more exact and proved difference in the survival rate of patients in both groups was not defined due to bladder cancer penetration. Conclusions: On the basis of the data received, the following conclusion can be made recurrence-free survival rate increases under maximum combined method usage for invasive bladder cancer.
Cited by 0 works.